| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |